Alector Shares Jump On $2.2B Immuno-Neurology Development Pact With GSK

Retrieved on: 2021-07-02 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Alector Shares Jump On $2.2B Immuno-Neurology Development Pact With GSK. View article details on hiswai:

Excerpt

... a global collaboration for the development and commercialization of two monoclonal antibodies designed to elevate progranulin (PGRN) levels.

Article found on: m.benzinga.com